Locations
Bayer Canada
Latest News
Health Canada grants marketing authorization for an additional indication of Bayer’s NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC)
Bayer Crop Science Canada Introduces Vyconic™ Soybeans, a Groundbreaking Advancement in Weed Management
EYLEA® HD pre-filled syringe with OcuClick™ dosing system granted marketing authorization in Canada
Advance Your Career
Our Businesses
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.